In Europe, approximately two million people suffer strokes each year—with the figure increasing substantially in recent years. Of that total, 78% percent are ischemic strokes, which occur when the blood supply to the brain is blocked. A new device from Cambell, CA based Lazarus Effect could offer hope to some of these patients. The company’s ReCover ischemic stroke device has received CE Mark approval, clearing the way for the device’s planned launch on the continent in the first quarter of 2013.
The device, which features a stent-based clot retriever with integrated protective cover made of nitinol mesh, is designed to prevent clot fragmentation or embolism and reduce the risk for secondary stroke during thrombectomy procedures. The design, which integrates protection directly onto a proven stent retriever design, could reduce the number of devices needed in thrombectomy procedures, explains Martin Dieck, chairman and CEO of the company.
Lazarus Effect plans on presenting the ReCover at this week’s Society for Neurointerventional Surgery (SNIS) Annual Meeting in San Diego. The company is working on a portfolio of products for treating ischemic stroke, which make use of patent-pending wire-frame technology.
Press release: Lazarus Effect ReCover™ Thrombectomy Device Receives CE Mark
Product page: ReCover…